화학공학소재연구정보센터
검색결과 : 227건
No. Article
1 Suspension State Promotes Drug Resistance of Breast Tumor Cells by Inducing ABCC3 Overexpression
Wang Y, Zhang XM, Zhao BY, Xu ZL, Lv YG
Applied Biochemistry and Biotechnology, 190(2), 410, 2020
2 Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Xu ZR, Han X, Ou DM, Liu T, Li ZX, Jiang GM, Liu J, Zhang J
Applied Microbiology and Biotechnology, 104(2), 575, 2020
3 BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells
Cheng XY, Huang Z, Long D, Jin W
Biochemical and Biophysical Research Communications, 521(4), 840, 2020
4 Crystal structure and transient dimerization for the FKBP12 protein from the pathogenic fungus Candida auris
Bashir Q, Li Z, Li HM, LeMaster DM, Hernandez G
Biochemical and Biophysical Research Communications, 525(4), 1103, 2020
5 Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer
Ochi K, Suzawa K, Tomida S, Shien K, Takano J, Miyauchi S, Takeda T, Miura A, Araki K, Nakata K, Yamamoto H, Okazaki M, Sugimoto S, Shien T, Yamane M, Azuma K, Okamoto Y, Toyooka S
Biochemical and Biophysical Research Communications, 529(3), 760, 2020
6 CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer
Zhou YH, Zheng M, Liu ZY, Yang HJ, Zhu P, Jiang JL, Tang J, Chen ZN
Biochemical and Biophysical Research Communications, 528(1), 62, 2020
7 EMT-inducing transcription factor ZEB1-associated resistance to the BCL-2/BCL-X-L inhibitor is overcome by BIM upregulation in ovarian clear cell carcinoma cells
Inoue-Yamauchi A, Oda H
Biochemical and Biophysical Research Communications, 526(3), 612, 2020
8 Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel
Li K, Li MH, Luo Z, Mao YL, Yu Y, He Y, Zhou J, Fei Y, Pei YX, Cai KY
Biochemical and Biophysical Research Communications, 526(2), 321, 2020
9 Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance
Yamazaki S, Su YH, Maruyama A, Makinoshima H, Suzuki J, Tsuboi M, Goto K, Ochiai A, Ishii G
Biochemical and Biophysical Research Communications, 526(1), 191, 2020
10 Low DEDD expression in breast cancer cells indicates higher sensitivity to the Bcl-2-specific inhibitor ABT-199
Liu DY, Qin XJ, Sun ZG, Hou SK, Lv Q
Biochemical and Biophysical Research Communications, 525(3), 549, 2020